Results 131 to 140 of about 124,514 (155)

Challenges in the Management of Infections due to Carbapenem-Resistant Enterobacteriaceae

Infection Control & Hospital Epidemiology, 2014
Carbapenem-resistant Enterobacteriaceae (CRE) infections are increasing and are associated with considerable morbidity and mortality. Members of the Emerging Infections Network treating CRE encountered difficulties in obtaining laboratory results and struggled with limited treatment options.
Dimitri M, Drekonja, Susan E, Beekmann, Sean, Elliott, Deepa, Mukundan, Hari, Polenakovik, Marnie E, Rosenthal, Pranita D, Tamma, Philip M, Polgreen, Scott J, Weissman   +8 more
openaire   +2 more sources

Susceptibility and Virulence of Enterobacteriaceae Isolated from Urinary Tract Infections in Benin

Microorganisms, 2023
Haziz Sina, Agossou Damien Pacôme Noumavo, Akim Socohou   +2 more
exaly  

Intra-Abdominal Infections by Carbapenemase-Producing Enterobacteriaceae in a Surgical Unit: Counting Mortality, Stay, and Costs

Surgical Infections, 2021
Ismael Mora-Guzmán, Inés Rubio-Perez, Elena Martín-Pérez   +2 more
exaly  

Clinical Impact of Revised Ciprofloxacin Breakpoint in Patients with Urinary Tract Infections by Enterobacteriaceae

Antibiotics, 2021
Jinkyeong Park, Jae-Hoon Ko, Sun Young Cho   +2 more
exaly  

Emergence of carbapenem-resistant Enterobacteriaceae as causes of bloodstream infections in patients with hematologic malignancies

Leukemia and Lymphoma, 2013
Michael J Satlin, Liang Chen, Stephen G Jenkins   +2 more
exaly  

Prevalence of ESBL-Producing Enterobacteriaceae in Pediatric Bloodstream Infections: A Systematic Review and Meta-Analysis

PLoS ONE, 2017
Styliani Karanika, Michail Alevizakos
exaly  

Enterobacteriaceae and Enteric Infections

2001
openaire   +1 more source

Risk Factors for Community-Acquired Urinary Tract Infections Caused by ESBL-Producing Enterobacteriaceae –A Case–Control Study in a Low Prevalence Country

PLoS ONE, 2013
Arne Søraas, Arnfinn Sundsfjord, Irène Sandven   +2 more
exaly  

Alternatives to carbapenems for infections caused by ESBL-producing Enterobacteriaceae

European Journal of Clinical Microbiology & Infectious Diseases, 2014
B, Pilmis, P, Parize, J R, Zahar, O, Lortholary   +3 more
openaire   +2 more sources

Clinical Outcomes, Drug Toxicity, and Emergence of Ceftazidime-Avibactam Resistance Among Patients Treated for Carbapenem-Resistant Enterobacteriaceae Infections: Table 1.

Clinical Infectious Diseases, 2016
Ryan K Shields, Brian A Potoski, Ghady Haidar   +2 more
exaly